Anti-ITIH5/ ITI-HC5/ PP14776 functional antibody

Anti-ITIH5/ ITI-HC5/ PP14776 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ITIH5/ITIH5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1041-Ab-1/ GM-Tg-hg-SE1041-Ab-2Anti-Human ITIH5 monoclonal antibodyHuman
GM-Tg-rg-SE1041-Ab-1/ GM-Tg-rg-SE1041-Ab-2Anti-Rat ITIH5 monoclonal antibodyRat
GM-Tg-mg-SE1041-Ab-1/ GM-Tg-mg-SE1041-Ab-2Anti-Mouse ITIH5 monoclonal antibodyMouse
GM-Tg-cynog-SE1041-Ab-1/ GM-Tg-cynog-SE1041-Ab-2Anti-Cynomolgus/ Rhesus macaque ITIH5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1041-Ab-1/ GM-Tg-felg-SE1041-Ab-2Anti-Feline ITIH5 monoclonal antibodyFeline
GM-Tg-cang-SE1041-Ab-1/ GM-Tg-cang-SE1041-Ab-2Anti-Canine ITIH5 monoclonal antibodyCanine
GM-Tg-bovg-SE1041-Ab-1/ GM-Tg-bovg-SE1041-Ab-2Anti-Bovine ITIH5 monoclonal antibodyBovine
GM-Tg-equg-SE1041-Ab-1/ GM-Tg-equg-SE1041-Ab-2Anti-Equine ITIH5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1041-Ab-1/ GM-Tg-hg-SE1041-Ab-2; GM-Tg-rg-SE1041-Ab-1/ GM-Tg-rg-SE1041-Ab-2;
GM-Tg-mg-SE1041-Ab-1/ GM-Tg-mg-SE1041-Ab-2; GM-Tg-cynog-SE1041-Ab-1/ GM-Tg-cynog-SE1041-Ab-2;
GM-Tg-felg-SE1041-Ab-1/ GM-Tg-felg-SE1041-Ab-2; GM-Tg-cang-SE1041-Ab-1/ GM-Tg-cang-SE1041-Ab-2;
GM-Tg-bovg-SE1041-Ab-1/ GM-Tg-bovg-SE1041-Ab-2; GM-Tg-equg-SE1041-Ab-1/ GM-Tg-equg-SE1041-Ab-2
Products NameAnti-ITIH5 monoclonal antibody
Formatmab
Target NameITIH5
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ITIH5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1041-Ag-1Recombinant multi-species ITIH5/ ITI-HC5/ PP14776 protein


    Target information

    Target IDGM-SE1041
    Target NameITIH5
    Gene ID80760,209378,684327,722614,100856779,101082755,534787,100070032
    Gene Symbol and Synonyms4631408O11Rik,5430408M01Rik,AABR07028488.1,E130106B02,ITI-HC5,ITIH5,PP14776
    Uniprot AccessionQ86UX2,A2VE29
    Uniprot Entry NameITIH5_HUMAN,ITIH5_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000123243
    Target ClassificationN/A

    The target: ITIH5, gene name: ITIH5, also named as ITI-HC5, PP14776. This gene encodes a heavy chain component of one of the inter-alpha-trypsin inhibitor (ITI) family members. ITI proteins are involved in extracellular matrix stabilization and in the prevention of tumor metastasis. They are also structurally related plasma serine protease inhibitors and are composed of a light chain and varying numbers of heavy chains. This family member is thought to function as a tumor suppressor in breast and thyroid cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.